Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederclinicaltrials.gov
ClinicalTrials.gov: Obesity and Overweight OR Type 2 Diabetes | Interventional studies | Funded by Industry | Last update posted in the last 14 days
Get the latest updates from ClinicalTrials.gov: Obesity and Overweight OR Type 2 Diabetes | Interventional studies | Funded by Industry | Last update posted in the last 14 days directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 6 hours ago
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
5 days ago
Conditions: Psoriasis; Overweight or Obesity Interventions: Drug: Tirzepatide Sponsors: Eli Lilly and...
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
5 days ago
Conditions: Type 2 Diabetes Interventions: Drug: LY3457263; Drug: Placebo Sponsors: Eli Lilly...
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
5 days ago
Conditions: Hypertension Interventions: Drug: Orforglipron; Drug: Placebo Sponsors: Eli Lilly and Company...
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
5 days ago
Conditions: Urinary Incontinence,Stress Interventions: Drug: Orforglipron; Drug: Placebo Sponsors: Eli Lilly and...
Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)
5 days ago
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: MK-2828; Drug: Placebo Sponsors: Merck...
Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
5 days ago
Conditions: Obesity Interventions: Drug: Semaglutide 2.4 mg; Drug: Placebo (semaglutide 2.4 mg)...
A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
5 days ago
Conditions: Obesity Interventions: Drug: Retatrutide; Drug: Placebo Sponsors: Eli Lilly and Company...
A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
5 days ago
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: LY3209590 Sponsors: Eli Lilly and...
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
5 days ago
Conditions: Osteoarthritis Interventions: Drug: Orforglipron; Drug: Placebo Sponsors: Eli Lilly and Company...
Lifestyle Program for Obstructive Sleep Apnea With Severe Obesity
5 days ago
Conditions: Obstructive Sleep Apnea; Obesity Interventions: Behavioral: Home-based pulmonary rehabilitation (PR) system...
A Study of LY3537031 in Overweight, Obese, and Healthy Participants
5 days ago
Conditions: Healthy; Obesity Interventions: Drug: LY3537031; Drug: Placebo Sponsors: Eli Lilly and...
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
5 days ago
Conditions: Ulcerative Colitis; Obesity or Overweight Interventions: Drug: Mirikizumab; Drug: Mirikizumab; Drug...